2013
DOI: 10.4137/vrt.s11754
|View full text |Cite
|
Sign up to set email alerts
|

Antigenic Variation in H5N1 clade 2.1 Viruses in Indonesia from 2005 to 2011

Abstract: Influenza A (H5N1) virus, has spread to several countries in the world and has a high mortality rate. Meanwhile, the virus has evolved into several clades. The human influenza A (H5N1) virus circulating in Indonesia is a member of clade 2.1, which is different in antigenicity from other clades of influenza A (H5N1). An analysis of the antigenic variation in the H5 hemagglutinin gene (HA) of the influenza A (H5N1) virus strains circulating in Indonesia has been undertaken. Several position of amino acid mutatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…The 71 selected specimens positive for influenza A(H5N1) virus with a Ct value below 35 were grown in 9-to 10-dayold specific pathogen-free (SPF) embryonated chicken eggs in a Biosafety Level 3 (BSL3) facility [26]. After incubation at 37 °C for 30 h, the egg allantoic fluid was harvested and hemagglutination titers were determined by hemagglutination assay.…”
Section: Specimen Isolation and Characterizationmentioning
confidence: 99%
“…The 71 selected specimens positive for influenza A(H5N1) virus with a Ct value below 35 were grown in 9-to 10-dayold specific pathogen-free (SPF) embryonated chicken eggs in a Biosafety Level 3 (BSL3) facility [26]. After incubation at 37 °C for 30 h, the egg allantoic fluid was harvested and hemagglutination titers were determined by hemagglutination assay.…”
Section: Specimen Isolation and Characterizationmentioning
confidence: 99%
“…However, the potential risk of antigenic variants of HPAIV H5N1 viruses evolving due to extensive use of H5 vaccine need to be considered as this may result in the failure of a vaccination programme (Setiawaty, Pratiwi, Pawestri, Ibrahim, & Soebandrio, 2013).…”
Section: Discussionmentioning
confidence: 99%